Niu Huanzhang, Gao Wanqin, Cheng Jingliang, Liu Baoping, Li Yundong, Huang Ke, Yang Hai
The Department of Imaging and Nuclear Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Hepatogastroenterology. 2012 Jul-Aug;59(117):1368-73. doi: 10.5754/hge11693.
BACKGROUND/AIMS: To evaluate the feasibility and clinical results of modified percutaneous transhepatic biliary internal-external drainage (PTBIED) vs. conventional PTBIED in patients with malignant biliary obstruction.
Conventional PTBIED was modified by applying side-holes to an 8.5Fr external biliary drainage catheter. Eligible patients were randomly assigned 1:1 by the doctors to receive modified PTBIED (group A) or conventional PTBIED (group B). Technical success rate, complications, hepatic function and white cell count were recorded pre- and post-procedure. All patients were followed-up until death.
Twenty-two patients were assigned in group A and 21 patients were involved in group B. Successful drainage was all achieved in both groups. Biliary tract infections were significantly reduced in group A (1/22) compared to group B (7/21, p<0.05). The leukocyte count fell slightly in group A post-procedure, while it rose in group B (group A: 8.45±3.22-109/L to 7.53±2.46-109/L; group B: 7.92±3.08-109/L to 10.52±5.09-109/L). Both procedures had similar effects in the recovery of hepatic function, median survival time and alleviating clinical symptoms (such as pruritis and abdominal pain).
Modified PTBIED can reduce the complications resulting from retrograde reflux of duodenal contents. Improved PTBIED should be used for patients with inoperable high malignant biliary obstruction.
背景/目的:评估改良经皮经肝胆道内外引流术(PTBIED)与传统PTBIED治疗恶性胆道梗阻患者的可行性及临床效果。
对传统PTBIED进行改良,在8.5Fr外引流导管上设置侧孔。符合条件的患者由医生按1:1随机分组,分别接受改良PTBIED(A组)或传统PTBIED(B组)。记录术前及术后的技术成功率、并发症、肝功能及白细胞计数。所有患者随访至死亡。
A组22例患者,B组21例患者。两组均成功实现引流。与B组(7/21)相比,A组(1/22)的胆道感染明显减少(p<0.05)。术后A组白细胞计数略有下降,而B组白细胞计数上升(A组:8.45±3.22×10⁹/L至7.53±2.46×10⁹/L;B组:7.92±3.08×10⁹/L至10.52±5.09×10⁹/L)。两种手术在肝功能恢复、中位生存时间及缓解临床症状(如瘙痒和腹痛)方面效果相似。
改良PTBIED可减少十二指肠内容物逆流引起的并发症。改良后的PTBIED应用于无法手术的高位恶性胆道梗阻患者。